Open AccessJournal Article
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
Shaul G. Massry,Jack W. Coburn,Glenn M. Chertow,Keith A. Hruska,Craig B. Langman,Hartmut H. Malluche,Kevin J. Martin,Linda McCann,James T. McCarthy,Sharon M. Moe,Isidro B. Salusky,Donald J. Sherrand,Miroslaw Smogorzewski,Kline Bolton,Charles Turkelson,Karyn A. Tappe,Stephen Tregear,James Reston,Wendy Bruening,Mark Monteforte,Janice Kaczmarek,Vivian Coates,George R. Bailie,Bryan N. Becker,Gavin J. Becker,Jerrilynn D. Burrowes,Fernando Carrera,David N. Churchill,Allan J. Collins,Peter W. Crooks,Dick DeZeeuw,Thomas A. Golper,Frank A. Gotch,Antonio M. Gotto,Roger Greenwood,Joel W. Greer,Richard H. Grimm,William E. Haley,Ronald J. Hogg,Alan R. Hull,Lawrence G. Hunsicker,Cynda Ann Johnson,Michael J. Klag,Saulo Klahr,Norbert Lameire,Francesco Locatelli,Sally McCulloch,Maureen Michael,Joseph V. Nally,John M. Newmann,Allen R. Nissenson,Keith C. Norris,Gregorio T. Obrador,William F. Owen,Thakor G. Patel,Glenda Payne,Claudio Ronco,Rosa A. Rivera-Mizzoni,Anton C. Schoolwerth,Robert A. Star,Michael W. Steffes,Theodore I. Steinman,John Pierre Wauters,Nanette K. Wenger,Josephine P. Briggs,Thomas H. Hostetter,Garabed Eknoyan,Aderra Levin,Nathan W. Levin,Sharon Andreoli,Sally Burrows-Hudson,Derrick Latos,Donna Mapes,Edith Oberley,Brian J.G. Pereira,Nadine Ferguson,Donna Fingerhut,Anthony Gucciardo,Margaret Klette,Doreen Mallard,Kerry Willis +80 more
Reads0
Chats0
About:
This article is published in American Journal of Kidney Diseases.The article was published on 2003-10-01 and is currently open access. It has received 2609 citations till now. The article focuses on the topics: Chronic kidney disease-mineral and bone disorder & Kidney disease.read more
Citations
More filters
Journal ArticleDOI
Activation of FGF-23 mediated vitamin D degradative pathways by cholecalciferol.
Hala M. Alshayeb,Arif Showkat,Barry M. Wall,Barry M. Wall,Geeta Gyamlani,Valentin David,L. Darryl Quarles +6 more
TL;DR: Modest elevations of serum 25(OH)D levels after cholecalciferol treatment are sufficient to induce compensatory degradative pathways in patients with sufficient renal reserves, suggesting that optimal circulating 25( OH)D Levels are approximately 20 ηg/mL.
Journal ArticleDOI
Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation
Kodo Tomida,Takayuki Hamano,Naotsugu Ichimaru,Naohiko Fujii,Isao Matsui,Norio Nonomura,Yoshiharu Tsubakihara,Hiromi Rakugi,Shiro Takahara,Yoshitaka Isaka +9 more
TL;DR: Renal phosphate wasting persists in the chronic-phase renal transplantation recipients even with normophosphatemia, in sharp contrast to the previous finding in the early phase that FGF23 levels are determinants of phosphate wasting.
Journal ArticleDOI
Effectiveness of cinacalcet in patients with recurrent/persistent secondary hyperparathyroidism following parathyroidectomy: results of the ECHO study
Emanuel Zitt,Marianne Rix,Pablo Ureña Torres,Denis Fouque,Stefan H. Jacobson,Frank Pétavy,Bastian Dehmel,Miroslav Ryba +7 more
TL;DR: The data support the successful use of cinacalcet in patients with recurrent/persistent sHPT after PTX with similar efficacy as seen in phase III trials.
Journal ArticleDOI
Association Between Serum Aluminum Level and Uremic Pruritus in Hemodialysis Patients.
Ching-Wei Hsu,Ching-Wei Hsu,Cheng-Hao Weng,Cheng-Hao Weng,Ming-Jen Chan,Dan-Tzu Lin-Tan,Tzung-Hai Yen,Tzung-Hai Yen,Wen-Hung Huang,Wen-Hung Huang +9 more
TL;DR: It is suggested that serum Al level may be associated with the development of UP in patients on maintenance HD and this cross-sectional study suggests that patients with higher serum Al levels had higher a prevalence of UP than those with lower serumAl levels.
Journal ArticleDOI
Lanthanum carbonate for the treatment of hyperphosphatemia in CKD 5D: multicenter, double blind, randomized, controlled trial in mainland China
Jing Xu,Yixiang Zhang,Xueqing Yu,Zhihong Liu,Lining Wang,Jianghua Chen,Ya-Ping Fan,Zhaohui Ni,Mei Wang,Fa-huan Yuan,Guo-Hua Ding,Xiangmei Chen,Ai-ping Zhang,Changlin Mei +13 more
TL;DR: Lanthanum carbonate is an efficacious and well-tolerated oral phosphate binder with a mild AE profile in hemodialysis and CAPD patients and may provide an alternative for the treatment of hyperphosphatemia in CKD 5D patients in mainland China.
References
More filters
Journal ArticleDOI
Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis
Geoffrey A. Block,Kevin J. Martin,Angel L.M. de Francisco,Stewart A. Turner,Morrell M. Avram,Michael Suranyi,Gavril Hercz,John Cunningham,Ali K. Abu-Alfa,Piergiorgio Messa,Daniel W. Coyne,Francesco Locatelli,Raphael M. Cohen,Pieter Evenepoel,Sharon M. Moe,Albert Fournier,Johann Braun,Laura C. McCary,Valter J. Zani,Kurt Olson,Tilman B. Drüeke,William G. Goodman +21 more
TL;DR: Cinacalcet lowers parathyroid hormone levels and improves calcium-phosphorus homeostasis in patients receiving hemodialysis who have uncontrolled secondary hyperparathyroidism.